What Key Growth Drivers Are Shaping The Polymerase Chain Reaction Molecular Diagnostics Market Forecast Toward $13.54 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Polymerase Chain Reaction Molecular Diagnostics Market Be Worth By 2029?
In the past few years, there has been a significant increase in the market size of the polymerase chain reaction molecular diagnostics. By 2025, the market is projected to reach $9.75 billion, up from $8.97 billion in 2024, reflecting a compound annual growth rate (CAGR) of 8.6%. The past period’s growth has been driven by a multitude of factors such as rising demand for early detection of illnesses, enhanced prevalence of infectious diseases, heightened awareness about genetic disorders, amplifying adoption of point-of-care testing, and climbing incidence of chronic illnesses.
The anticipated growth of the polymerase chain reaction molecular diagnostics market over the coming years looks robust and is predicted to escalate to $13.54 billion by 2029, indicating an 8.6% compound annual growth rate (CAGR). Several factors contribute to this projected growth during the forecast period, including the escalating incidence of cancer, an increasing inclination towards personalized medicine, rising investment in molecular diagnostics, a burgeoning demand for swift diagnostic tests, and an expanding interest in non-invasive prenatal testing. Key forecast period trends comprise advancements in diagnostic technologies, evolution in point-of-care polymerase chain reaction systems, innovative strides in multiplex polymerase chain reaction, the amalgamation of polymerase chain reaction with microfluidics, and enhancements in digital polymerase chain reaction platform technologies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp
What Market Forces Are Contributing To The Growth Of The Polymerase Chain Reaction Molecular Diagnostics Market?
The upward trend of infectious diseases is anticipated to bolster the development of the polymerase chain reaction molecular diagnostics market. Infectious diseases are those caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites which can be directly or indirectly passed from one individual to another. The rise of these diseases is fueled by the emergence of antibiotic-resistant pathogens, posing a challenge to treatment and containment. These pathogens result in extended illnesses, elevated healthcare expenses, and increased public health dangers. Polymerase chain reaction (PCR) molecular diagnostics contribute to improved management of infectious diseases, by enabling prompt and precise detection of pathogens at the genetic level. This encourages early diagnosis and precise treatment, consequently enhancing healthcare outcomes through immediate interventions, limiting infection spread, and ensuring optimal patient care. For example, in November 2023, the Department of Health and Human Services, a government agency based in the US, reported that newly diagnosed chronic hepatitis B cases (a viral infection affecting the liver, leading to acute and chronic disease) increased by 11% in 2022 compared to 2021. As such, the growing incidence of infectious diseases is fuelling the expansion of the polymerase chain reaction molecular diagnostics market.
Which Segments Define The Structure Of The Polymerase Chain Reaction Molecular Diagnostics Market?
The polymerase chain reaction molecular diagnosticsmarket covered in this report is segmented –
1) By Product Type: Instrument; Reagents And Consumables; Software
2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software
Which Long-Term Trends Will Play A Crucial Role In The Polymerase Chain Reaction Molecular Diagnostics Market?
Major participants in the polymerase chain reaction molecular diagnostics market are prioritizing the development of technologically superior solutions, including benchtop instruments, to improve testing productivity and convenience. Benchtop instruments are compact, lab-compatible devices that can fit on a laboratory worktop or desk, which are utilized for scientific, medical, or industrial inspections and evaluations. For example, QIAGEN N.V., a biotechnology company from Germany, introduced the QIAcuityDx Digital PCR System designed for clinical oncology testing in September 2024. This system is completely automated, integrating partitioning, thermocycling, and imaging into one apparatus, providing precise quantification of deoxyribonucleic acid and ribonucleic acid with outcomes delivered within roughly two hours and negligible hands-on involvement. The system caters for up to five detection channels for multiplexing and supports ongoing nanoplate loading. It offers both validated and flexible research modes, rendering it flexible for a range of clinical and laboratory requirements.
Which Firms Are Making The Biggest Impact In The Polymerase Chain Reaction Molecular Diagnostics Market?
Major companies operating in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Polymerase Chain Reaction Molecular Diagnostics Market In The Coming Years?
North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp
Browse Through More Reports Similar to the Global Polymerase Chain Reaction Molecular Diagnostics Market 2025, By The Business Research Company
Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025
Colorectal Cancer Molecular Diagnostics Global Market Report 2025
Molecular Biology Enzymes And Kits And Reagents Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
